Abstract
Aim: To develop and validate internally a multivariate risk model for predicting the in-hospital mortality of patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with mid-range ejection fraction (HFmrEF). Methods & results: The clinical data of 8172 inpatients with HFpEF and HFmrEF was used to establish a retrospective database. These patients, among whom 307 in-hospital deaths (3.8%) occurred, were randomly assigned to derivation and verification cohort. Among the extracted data from the derivation cohort were nine variables significantly related to in-hospital mortality, which were scored 0–4, for a total score of 24, which allowed formation of a risk predictive model. The verification cohort was then used to validate the discrimination and calibration capacities of this predictive model: the area under curve equaled 0.8575 (0.8285, 0.8865) for the derivation cohort, and 0.8323 (0.7999, 0.8646) for the verification cohort. According to this risk score, we divided patients into four risk classes (low-, medium-, high- and extremely high-risk) and revealed that the risk of in-hospital mortality increased with increasing risk class with an obvious linear relationship between actual and predicted mortality (r = 0.998, p < 0.001). Conclusion: The model based on nine common clinical variables should provide an accurate prediction of in-hospital mortality and appears to be a reliable risk classification system for patients with HFpEF and HFmrEF.
Papers of special note have been highlighted as: • of interest
References
- 1. Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. Am. Heart J. 160(5), 88–92 (2010).
- 2. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J. Am. Coll. Cardiol. 52(5), 347–356 (2008).
- 3. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128(16), 1810–1852 (2013).
- 4. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000–2017: population based cohort study. BMJ 364, l223 (2019).
- 5. . Heart failure. Lancet 390, 1981–1995 (2017).
- 6. The Seattle Heart Failure Model prediction of survival in heart failure. Circulation 113(11), 1424–1433 (2006). • The earliest predictive model of heart failure.
- 7. Predictors of mortality and morbidity in patients with chronic heart failure. Eur. Heart J. 27(1), 65–75 (2006).
- 8. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am. Heart J. 156(4), 662–673 (2008).
- 9. Predicting survival in heart failure: a risk score based on 39,372 patients from 30 studies. Eur. Heart J. 34(19), 1404–1413 (2013).
- 10. The 3A3B score: the simple risk score for heart failure with preserved ejection fraction – a report from the CHART-2 Study. Int. J. Cardiol. 284, 42–49 (2019). • A simple risk score for predicting the long-term outcomes of patients with heart failure with preserved ejection fraction.
- 11. A validated risk score for in-hospital mortality in patients with heart failure from the American heart association get with the guidelines program. Circ. Cardiovasc. Qual. Outcomes 3(1), 25–32 (2010). • The GWTG-HF risk score showed seven admission variables predicted in-hospital mortality.
- 12. . 2017 Epidemiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 14(10), 591–602 (2017).
- 13. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur. Heart J. 33(14), 1750–1757 (2012). • MAGGIC models: Meta-Analysis Global Group in Chronic Heart Failure for long-term outcomes.
- 14. . Heart failure with preserved ejection fraction in perspective. Circ. Res. 124(11), 1598–1617 (2019).
- 15. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Int. J. Cardiol. 257, 188–192 (2018).
- 16. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J. Am. Coll. Cardiol. 64(21), 2281–2293 (2014).
- 17. The PROTECT in- hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. Eur. J. Heart Fail. 14(6), 605–612 (2002).
- 18. Prediction of survival in Asian patients hospitalized with heart failure: validation of the OPTIMIZE-HF Risk Score. J. Card. Fail. 25(7), 571–575 (2019).
- 19. Prognostic value of high-sensitivity troponin T in chronic heart failure an individual patient data meta-analysis. Circulation 137(3), 286–297 (2018).
- 20. High-sensitivity cardiac troponin I levels and prediction of heart failure results from the BiomarCaRE consortium. JACC Heart Fail. 8(5), 401–411 (2020).
- 21. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: a multimarker strategy for risk stratification in chronic heart failure. Int. J. Cardiol. 277, 166–172 (2019).
- 22. Blood urea nitrogen variation upon admission and at discharge in patients with heart failure. ESC Heart Fail. 6(4), 809–816 (2019).
- 23. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur. J. Intern. Med. 43, 36–41 (2017).
- 24. Prognostic significance of baseline serum sodium in heart failure with preserved ejection fraction. J. Am. Heart Assoc. 7(12), e007529 (2018).
- 25. Association of visit to visit variability in kidney-function and serum electrolyte indexes with risk of adverse clinical outcomes among patients with heart preserved ejection fraction. JAMA Cardiol. 6(1), 68–77 (2021).
- 26. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21,334 patients in the UK. ESC Heart Fail. 6(2), 280–290 (2019).
- 27. The association between serum calcium levels and short-term mortality in patients with chronic heart failure. Am. J. Med. 132(2), 200–208 (2019).
- 28. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ. Heart Fail. 4(2), 180–187 (2011).
- 29. Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment. Int. J. Cardiol. 284, 50–58 (2019).
- 30. Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: the Henry Ford Exercise Testing (FIT) Project. Arch. Med. Sci. 15(2), 350–358 (2019).
- 31. . Serum albumin level and hospital mortality in acute non-ischemic heart failure. ESC Heart Fail. 4(2), 138–145 (2017).
- 32. . Reappraising the role of inflammation in heart failure. Nat. Rev. Cardiol. 17(5), 269–285 (2020).